Men increasingly use herbal remedies to treat bothersome lower urinary tract symptoms due to benign prostatic hyperplasia. Yet, study results with these products are inconsistent.
Researchers from Princess Margaret Hospital, in Toronto, Ontario think it might be due to contamination of these products Continue reading Searching for contamination in herbals used to treat benign prostatic hyperplasia
Research suggests that cannabis use has a negative effect on onset and outcome of schizophrenia.
Now, researchers at Eli Lilly Nederland at Houten, The Netherlands report, “cannabis users experienced less satisfaction with life and had a lower probability of having a relationship compared with nonusers.” Continue reading Negative effects of cannabis in bipolar disorder
Researchers from the University of Patras Medical School in Greece have reviewed the data.
Continue reading The status of marijuana in multiple sclerosis
The Cochrane review concludes there’s not enough supporting data. Continue reading Cannabinoids to treat Tourette’s Syndrome?
For over 2 decades, cannabis (marijuana) has been the most widely used illicit drug by young people in high-income countries, and has become popular on a global scale.
Researchers from the University of Queensland, in Herston, Australia reviewed the adverse effects. Continue reading Adverse effects of non-medical cannabis
Most people with emphysema are older men.
Marijuana abuse should be considered as a reason for development of emphysema in young people, according to researchers from University Hospital Berne, in Switzerland. Continue reading Lung emphysema in marijuana smokers
Researchers from Mayo Clinic, in Scottsdale, Arizona reviewed the evidence. Continue reading Do cannabinoids reduce multiple sclerosis-related spasticity?
People with schizophrenia frequently report benefit from cannabis use. Yet, cannabis may be a risk factor for schizophrenia.
Researchers from the University of Bergen, in Norway reviewed the medical research for a connection. Continue reading Review: Cannabis use in schizophrenia
These are the results of a laboratory study by researchers at the University of Leicester, in the UK. Continue reading Cannabis alters DNA and might increase cancer risk
Researchers from Royal Hallamshire Hospital, in Sheffield, UK studied Sativex, a cannabis based medicinal extract. Continue reading Medicinal cannabis no different than placebo for painful diabetic neuropathy
Attorney General Eric Holder says the US Justice Department will no longer raid medical marijuana clubs. His declaration is a fulfillment of a campaign promise by Barack Obama, and marks a major shift from the previous administration.
In fact, there’s scant support for medical marijuana based on medical science. Here’s what’s been published in just the past 6 months. Continue reading Marijuana: Politics trumps reality
Approximately 6.8 million Americans suffer from generalized anxiety disorder. It’s not surprising then that there’s interest in finding effective natural treatments.
The Global Neuroscience Initiative Foundation, in Los Angeles, California, reviewed the evidence for passionflower, lysine, magnesium, kava, and St John’s wort, alone or in combination. Continue reading Nutritional herbal supplements for treating anxiety
Drugs and Therapeutics Bulletin, which is published by the British Medical Journal, has published their review of the evidence. Continue reading Little evidence that herbals relieve menopause symptoms
Researchers from Kyung Hee University in Seoul, Republic of Korea studied Asian ginseng (Panax ginseng) and found no interaction with the blood thinner, warfarin (Coumadin). Continue reading The ginseng/warfarin interaction debate
Pine bark extract is a dietary antioxidant supplement.
In this study, researchers at Stanford University School of Medicine, in California, attempt to correct past studies that they consider flawed. Continue reading No effect of pine bark extract on cardiovascular disease risk
Researchers at the Universitetet i Oslo, tell us, “Since 2004, glucosamine has been available as a prescription drug [in Norway] for symptomatic treatment of mild to moderate osteoarthritis.
The aim of this study was evaluate the use of glucosamine on the need for analgesic drugs. Continue reading Failure of glucosamine to reduce the use of pain relieving drugs
Researchers from several US medical schools surveyed the students. Continue reading Survey of American medical students about CAM
Dr. Mark Moyad (photo) is Director of Preventive and Alternative Medicine at the University of Michigan Medical Center in Ann Arbor.
His recommendations. Continue reading CAM to treat the cold and flu
Dr. Cecile Henquet, of the Department of Psychiatry and Neuropsychology at the University of Maastricht, presented a summary of what we know during the 23rd European College of Neuropsychopharmacology Congress.
Here are the highlights of an interview on Medscape. Continue reading Update: Cannabis and the risk of psychosis
Chronic pain is associated with depression.
Self-treatment of that depression with St John’s wort makes pain patients prone to a drug interaction with the potent pain drug, oxycodone (OxyContin), according to this study by researchers at the University of Turku, in Finland. Continue reading St. John’s wort interaction with oxycodone